These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8732755)

  • 1. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
    Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
    Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
    Bridon DP; Dowell BL
    Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma.
    Hekim C; Riipi T; Zhu L; Laakkonen P; Stenman UH; Koistinen H
    Prostate; 2010 Apr; 70(5):482-90. PubMed ID: 19937596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
    Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural model of human PSA: a target for prostate cancer therapy.
    Hassan MI; Kumar V; Singh TP; Yadav S
    Chem Biol Drug Des; 2007 Sep; 70(3):261-7. PubMed ID: 17718721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.
    Kumar A; Mikolajczyk SD; Goel AS; Millar LS; Saedi MS
    Cancer Res; 1997 Aug; 57(15):3111-4. PubMed ID: 9242434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
    Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
    Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
    Denmeade SR; Lövgren J; Khan SR; Lilja H; Isaacs JT
    Prostate; 2001 Jul; 48(2):122-6. PubMed ID: 11433422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
    Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
    Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of prostate specific antigen and human glandular kallikrein structures.
    Vihinen M
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1251-6. PubMed ID: 7526861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical conditions affecting the formation/stability of serum complexes and the determination of prostate-specific antigen (PSA).
    Kioukia-Fougia N; Christofidis I; Strantzalis N
    Anticancer Res; 1999; 19(4B):3315-20. PubMed ID: 10652627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
    Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
    Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.